AI Article Synopsis
Article Abstract
Background: In hemorrhagic shock (HS), volume replacement with crystalloid solution can restore the hemodynamic status and decrease mortality. However, it can also lead to tissue edema and pulmonary congestion, as well as increasing vascular permeability. Here, we analyzed the effects that resuscitation with lactated Ringer's solution (LRS) or administration of the vasopressin analog terlipressin has on renal function in a porcine model of HS.
Methods: Using pressure-controlled bleeding, we induced pigs to HS, maintaining mean arterial pressure (MAP) at 40 mm Hg for 30 min. Animals were divided into 4 groups: sham (anesthesia only); shock-only (HS induction); shock+LRS (HS induction and subsequent resuscitation with LRS at 3 times the volume of blood removed); and shock+Terli (HS induction and subsequent bolus administration of 2 mg of terlipressin). Parameters were evaluated at baseline, then at 30, 60, and 120 min after treatment (T30, T60, and T120, respectively). Animals were euthanized at T60 or T120.
Results: Both treatments restored MAP to baseline values. At T30 and T60, creatinine clearance was highest in shock+LRS pigs, whereas it was highest in shock+Terli pigs at T120. Both treatments initially induced hyponatremia, although urinary excretion of all ions was higher in shock+LRS pigs at T30. Both treatments restored Na-K-2Cl cotransporter expression, whereas only terlipressin restored aquaporin 2 expression. Both treatments also prevented HS-induced acute tubular necrosis. Expression of the vasopressin receptors V1a and V2 was highest in shock-only pigs. At T120, V1a expression was lowest in shock+LRS pigs.
Discussion: Terlipressin might be useful for preventing HS-induced acute kidney injury.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891712 | PMC |
| http://dx.doi.org/10.1136/tsaco-2016-000039 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Application of Terlipressin in the Management of Ascites in Liver Cirrhosis: Current Status and Prospects.
Br J Hosp Med (Lond)
November 2024
Internal Medicine Department II, Xianju County Traditional Chinese Medicine Hospital, Taizhou, Zhejiang, China.
Ascites due to liver cirrhosis is a common complication in patients with liver disease, severely affecting their prognosis and quality of life. Traditional treatment methods have significant limitations in managing ascites, highlighting the need for new therapeutic approaches. As an antidiuretic drug, terlipressin has shown good efficacy and potential in treating ascites.
View Article and Find Full Text PDFSelf-assembly, cytocompatibility, and interactions of desmopressin with sodium polystyrene sulfonate.
Soft Matter
December 2024
Departamento de Biofísica, Universidade Federal de São Paulo, São Paulo 04062-000, Brazil.
Peptide-polymer systems hold strong potential for applications in nanotherapeutics. Desmopressin, a synthetic analogue of the antidiuretic hormone arginine vasopressin, may serve as a valuable case of study in this context since it is a first-line treatment for disorders affecting water homeostasis, including diabetes insipidus. It also has an established use as a hemostatic agent in von Willebrand disease, and recently, its repurposing has been suggested as a neoadjuvant in the treatment of certain types of cancer.
View Article and Find Full Text PDFDrug therapy versus placebo or usual care for comatose survivors of cardiac arrest; a systematic review with meta-analysis.
Resuscitation
December 2024
Regional Intensive Care Unit, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, UK; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, UK. Electronic address:
Background: In Europe, approximately 291,000 cardiac arrests occur annually. Despite critical care therapy, hospital mortality remains high. This systematic review assessed whether, in comatose survivors of cardiac arrest, any drug therapy, compared to placebo or usual care, improves outcomes.
View Article and Find Full Text PDFAdipsic arginine vasopressin deficiency: challenges in managing the intricate interplay of adipsia with polyuria.
BMJ Case Rep
October 2024
Endocrinology and Metabolism, All India Institute of Medical Science, Bhopal, Madhya Pradesh, India
Article Synopsis
- Adipsic arginine vasopressin deficiency (AAVP-D) occurs due to hypothalamic dysfunction, often linked to conditions like craniopharyngiomas, which makes management difficult since key mechanisms for regulating plasma osmolality are impaired.
- Patients with AAVP-D can suffer from severe dehydration and elevated sodium levels (hypernatraemia), leading to frequent emergency visits despite treatment with desmopressin, an arginine vasopressin analogue.
- A case study highlights the successful management of AAVP-D through careful water intake regulation and desmopressin administration, resulting in stable serum sodium levels (140-150 mmol/L) and no emergency visits over a three-month period.
The small-for-size syndrome in living donor liver transplantation: current management.
Updates Surg
October 2024
Department of Liver Transplantation, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Small-for-size syndrome poses a significant challenge in living donor liver transplantation, with potentially severe consequences including liver failure and death. This review explores the management strategies for SFSS, starting from the pathophysiology of the disease. SFSS arises from insufficient liver mass in the graft and hyperdynamic circulation in cirrhotic recipients, leading to portal hyperperfusion and subsequent liver injury.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!